Citation Impact
Citing Papers
FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
2004 Standout
A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism
2008
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
2001
Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro
2008
Understanding the Link Between Information Technology Capability and Organizational Agility: An Empirical Examination1
2011 Standout
Shaping Agility through Digital Options: Reconceptualizing the Role of Information Technology in Contemporary Firms1
2003 Standout
Competing Perspectives on the Link between Strategic Information Technology Alignment and Organizational Agility: Insights from a Mediation Model1
2011 Standout
Progress in information technology and tourism management: 20 years on and 10 years after the Internet—The state of eTourism research
2008 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Digital transformation: A multidisciplinary reflection and research agenda
2019 Standout
FGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX Substrate
2001
Latest findings in phosphate homeostasis
2009
Social networks, travel and talk1
2003
The FGF family: biology, pathophysiology and therapy
2009 Standout
Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis
2012
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Gene doping: an overview and current implications for athletes
2013
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
2009
Acromegaly pathogenesis and treatment
2009
Head and neck cancer
2008 Standout
Characterization of Mammalian Stanniocalcin Receptors
2002
Genetic Disorders of Renal Phosphate Transport
2010
Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients
2006
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
2001 Standout
Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia
2003
Osteoarthritis
2015 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Calcium and phosphate homeostasis: Concerted interplay of new regulators
2008
The current status of IGF-I assays – A 2009 update
2009
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
2011 Standout
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
2004
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
2004 Standout
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
PHEX gene and hypophosphatemia
2000
Klotho converts canonical FGF receptor into a specific receptor for FGF23
2006 StandoutNature
Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent
2003
Doping and musculoskeletal system: short‐term and long‐lasting effects of doping agents
2010
Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate
2010
Tumours of familial origin in the head and neck
2006
A polymerase chain reaction-based methodology to detect gene doping
2011
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Strategy and business models - strange bedfellows? A case for convergence and its evolution into strategic architecture
2004
Magnesium in Man: Implications for Health and Disease
2014 Standout
What We Know and Don’t Know About Corporate Social Responsibility
2012 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Detection of EPO gene doping in blood
2012
High-Sensitivity Chemiluminescence Immunoassays for Detection of Growth Hormone Doping in Sports
2009
Corporate Social Responsibility, Customer Satisfaction, and Market Value
2006 Standout
With or without the kidney: the role of FGF23 in CKD
2005
The Tumor Lysis Syndrome
2011 Standout
The Relationship Between Corporate Philanthropy And Shareholder Wealth: A Risk Management Perspective
2005 Standout
Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations
2014
The Impact of Corporate Sustainability on Organizational Processes and Performance
2014 Standout
Ovarian cancer statistics, 2018
2018 Standout
Dietary Phosphorus Regulates Serum Fibroblast Growth Factor-23 Concentrations in Healthy Men
2006
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
2004 Standout
Strategy–organization configurations in corporate venture units: Impact on performance and survival
2007
Customer Experience Creation: Determinants, Dynamics and Management Strategies
2009 Standout
The Business Model: Recent Developments and Future Research
2011 Standout
Organizational Ambidexterity: Antecedents, Outcomes, and Moderators
2008 Standout
CROSSROADS—Microfoundations of Performance: Balancing Efficiency and Flexibility in Dynamic Environments
2010 Standout
Information systems strategy: Past, present, future?
2012
The Applicability of Porter’s Generic Strategies in the Digital Age: Assumptions, Conjectures, and Suggestions
2004
The relationship between corporate social responsibility and shareholder value: an empirical test of the risk management hypothesis
2008 Standout
Open innovation in SMEs: Trends, motives and management challenges
2008 Standout
Service Quality in Multichannel Services Employing Virtual Channels
2006
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Knowledge sharing: A review and directions for future research
2009 Standout
Focusing on Value: Reconciling Corporate Social Responsibility, Sustainability and a Stakeholder Approach in a Network World
2003
Value creation in E‐business
2001 Standout
Unravelling the process from Closed to Open Innovation: evidence from mature, asset‐intensive industries
2010
Corporate Social Responsibility Theories: Mapping the Territory
2004 Standout
Unveiling the impact of the adoption of digital technologies on firms’ innovation performance
2021 Standout
Why have ovarian cancer mortality rates declined? Part I. Incidence
2015
Growth Hormone Doping in Sports: A Critical Review of Use and Detection Strategies
2012
How open is innovation?
2010 Standout
The New Mobilities Paradigm
2006 Standout
Enterprise agility and the enabling role of information technology
2006
The amazing osteocyte
2010 Standout
Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
2000
Angiogenesis in Endocrine Tumors
2003
Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism
2002
Business Models, Business Strategy and Innovation
2009 Standout
Putting the S back in corporate social responsibility: A multilevel theory of social change in organizations
2007 Standout
Vascular Calcification
2008 Standout
Corporate Social Responsibility, Customer Satisfaction, and Market Value
2006 Standout
Works of Anne E. Nelson being referenced
Toward an Understanding of Global Entrepreneurial Knowledge Management (EKM) Practices: A Preliminary Investigation of EKM in France and the U.S
2006
External Corporate Venturing: Strategic Renewal in Rapidly Changing Industries
2003
Bone as a source of FGF23: regulation by phosphate?
2004
Growth Hormone in Sports: Detecting the Doped or Duped
2011
The PEX gene: not a simple answer for X-linked hypophosphataemic rickets and oncogenic osteomalacia
1997
Erythropoietin administration does not influence the GH–IGF axis or makers of bone turnover in recreational athletes
2005
Characteristics of tumor cell bioactivity in oncogenic osteomalacia
1996
Fibroblast Growth Factor 23: A New Clinical Marker for Oncogenic Osteomalacia
2003
A robust test for growth hormone doping – present status and future prospects
2008
Growth hormone and physical performance
2011
Abuse of growth hormone by athletes
2007
Demographic factors influencing the GH system: Implications for the detection of GH doping in sport
2009
Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
2000
Proteomic Profiling of Growth Hormone-Responsive Proteins in Human Peripheral Blood Leukocytes
2009
Pharmacodynamics of Growth Hormone Abuse Biomarkers and the Influence of Gender and Testosterone: A Randomized Double-Blind Placebo-Controlled Study in Young Recreational Athletes
2008
Within-Subject Variability and Analytic Imprecision of Insulinlike Growth Factor Axis and Collagen Markers: Implications for Clinical Diagnosis and Doping Tests
2008
Detection of Growth Hormone Doping by Gene Expression Profiling of Peripheral Blood
2009
Blown to bits: How the new economics of information transforms strategy
2000
Reducing Time to Diagnosis Does Not Improve Outcomes for Women With Symptomatic Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
2011
Mutational Analysis and Genotype-Phenotype Correlation of the PHEX Gene in X-Linked Hypophosphatemic Rickets
2001
Influence of Demographic Factors and Sport Type on Growth Hormone-Responsive Markers in Elite Athletes
2006
The Effects of Growth Hormone on Body Composition and Physical Performance in Recreational Athletes
2010